ライフサイエンスコーパス: urinary tract

1 without bacterial and viral infection of the urinary tract.

2 t and cloaca, analogs of the mammalian lower urinary tract.

3 athogenic E. coli (UPEC) colonisation of the urinary tract.

4 nd/or congenital anomalies of the kidney and urinary tract.

5 l nitrogen and carbon source for UPEC in the urinary tract.

6 normal fat density in non-contrast CT of the urinary tract.

7 tection against pathogen colonization of the urinary tract.

8 among the most common pathogens of the human urinary tract.

9 Urothelium is the protective lining of the urinary tract.

10 balance, and clearance of bacteria from the urinary tract.

11 matory disorders of the gastrointestinal and urinary tracts.

12 ial cells of the gastrointestinal and genito-urinary tracts.

13 common infection sources were lung (43%) and urinary tract (17%); in 22% of cases, infection source r

14 h pneumonia (27.1%), intraabdominal (19.5%), urinary tract (20.0%), or skin and skin structure infect

15 ction sites were skin and soft tissue (39%), urinary tract (23%), bone and joint (16%), and bloodstre

16 s and that is only minimally excreted by the urinary tract, a potential advantage for pelvic imaging.

17 rent episodes of febrile UTI should focus on urinary tract abnormalities, whereas in cases of cystiti

18 biome analysis from the gastrointestinal and urinary tracts, along with a metabolomic analysis of the

19 and oral cavity, preliminary surveys of the urinary tract and bladder microbiota indicate a rich div

20 ulates state-dependent reflexes in the lower urinary tract and contribute to our understanding of the

21 l roles for the urothelium in the developing urinary tract and in the genesis of CAKUTs.

22 routine medical care to diagnose kidney and urinary tract and metabolic diseases.

23 ng) to the quantification of the severity of urinary tract and periprosthetic joint infections.

24 floxacin completely eradicates UPEC from the urinary tract and prevents the development of relapsing

25 mentally changed current dogma regarding the urinary tract and related urinary disorders.

26 lactamase inhibitor for treating complicated urinary tract and respiratory infections caused by multi

27 itability of afferent nerves innervating the urinary tract and the bowel, respectively.

28 as CAKUT (Congenital anomalies of kidney and urinary tract) and esophageal atresia.

29 w into bacterial and viral infections of the urinary tract, and can find future use as a tool for the

30 ces of polymicrobial interactions within the urinary tract, and the clinical significance of polymicr

31 ; effects on the reproductive, digestive, or urinary tract; and safety in poor sanitary conditions.

32 It comprises complex urinary tract anomalies, bilateral undescended testis an

33 Children with urinary tract anomalies, premature birth, or major comor

34 Endometriosis of the bowel and urinary tract are types of extragenital endometriosis th

35 folds and protein localization in the lower urinary tract at critical periods for forebrain division

36 g small locoregional lesions adjacent to the urinary tract but may decrease the interpretability of s

37 ny of the bacterial components of the female urinary tract, but the viral fraction of this community

38 Congenital anomalies of the kidney and urinary tract (CAKUT) are a major cause of pediatric kid

39 Congenital anomalies of the kidney and urinary tract (CAKUT) are one of the most common malform

40 Congenital anomalies of the kidneys and urinary tract (CAKUT) are the leading cause of CKD in ch

41 Congenital anomalies of the kidney and urinary tract (CAKUT) are the most common cause of chron

42 Congenital anomalies of the kidney and urinary tract (CAKUT) are the most common cause of CKD i

43 Congenital anomalies of the kidneys and urinary tract (CAKUT) comprise a large spectrum of conge

44 Congenital anomalies of the kidney and urinary tract (CAKUT) constitute one of the most frequen

45 Congenital anomalies of the kidney and urinary tract (CAKUT) occur in three to six of 1000 live

46 se of congenital anomalies of the kidney and urinary tract (CAKUT).

47 Congenital anomalies of the kidney and urinary tract (CAKUTs) represent the leading cause of ch

48 gastrointestinal hemorrhage, renal failure, urinary tract calculus, chronic ulcer of skin, and back

49 al species in the milieu of the catheterized urinary tract can directly impact prognosis.

50 We assessed risk for urinary tract cancers in kidney recipients with or witho

51 owed a significant association with lung and urinary tract cancers.

52 e biomarkers and their performance in common urinary tract cancers.

53 mportant in health and ailments of the lower urinary tract cause high pathological burden.

54 The outcome was a hospital admission for urinary tract causes (defined by an expert study steerin

55 six reports of allergies or rashes, nine of urinary tract complaints (three with hydronephrosis), an

56 arlet fever, pyelonephritis, and complicated urinary tract conditions.

57 cted, asymptomatic individuals without known urinary tract conditions.

58 studies assessing RNase 7's contributions to urinary tract defense are limited.

59 ptibility gene for CBE and as a regulator of urinary tract development.

60 Patients were excluded if they had upper urinary tract disease, urothelial carcinoma within the p

61 gnosis and management of patients with lower urinary tract disorders.

62 ociated with clinical failure, whereas early urinary tract drainage procedures (surgical, percutaneou

63 and of the recruitment of neutrophils to the urinary tract during infection.

64 omponent of the clinical evaluation of lower urinary tract dysfunction and include filling cystometry

65 ould prevent development of neurogenic lower urinary tract dysfunction, in particular detrusor sphinc

66 ould prevent development of neurogenic lower urinary tract dysfunction.

67 causal treatment option for neurogenic lower urinary tract dysfunction.

68 Secondary analyses evaluated non-urinary tract hospitalized infections and 30-day readmis

69 li are detected inside vaginal cells and the urinary tract, indicating that vaginal colonization can

70 ryngitis (38 [14%] vs 36 [12%] vs 39 [15%]), urinary tract infection (19 [7%] vs 11 [4%] vs 13 [5%]),

71 95% CI: 0.97-2.84; I2: 86%; p-value = 0.06), urinary tract infection (4,493 FGM/C and 3,776 non-FGM/C

72 was consistent across infection subtypes of urinary tract infection (482 cases), cellulitis/osteomye

73 h bempedoic acid and placebo, respectively), urinary tract infection (5.0% vs 1.9%), and hyperuricemi

74 events [6.1%]; placebo, 105 events [5.8%]), urinary tract infection (aclidinium, 93 events [5.2%]; p

75 hat most commonly define catheter-associated urinary tract infection (CAUTI) and encourage further ex

76 Catheter associated urinary tract infection (CAUTI) is the most common healt

77 p the first A. baumannii catheter-associated urinary tract infection (CAUTI) murine model using UPAB1

78 tals struggle to prevent catheter-associated urinary tract infection (CAUTI).

79 en and frequent cause of catheter-associated urinary tract infection (CAUTI).

80 being developed for treatment of complicated urinary tract infection (cUTI) and acute pyelonephritis

81 rimegepant n=11 [2%]; placebo n=3 [<1%]) and urinary tract infection (rimegepant n=10 [1%]; placebo n

82 Recurrent urinary tract infection (rUTI) is a major medical proble

83 group), pneumonia (training: 2, control: 0), urinary tract infection (training: 2, control: 0), dehyd

84 pyrexia (three [4%]), diarrhoea (two [3%]), urinary tract infection (two [3%]), and acute kidney inj

85 ravelers' diarrhea (TD) (75/90 subjects) and urinary tract infection (UTI) (3/90).

86 0) is a leading cause of multidrug-resistant urinary tract infection (UTI) and bloodstream infection

87 spitalized patients treated for pneumonia or urinary tract infection (UTI) and determine whether over

88 tected escherichelin during clinical E. coli urinary tract infection (UTI) and experimental human col

89 ive/adjunct screening tool to UA to rule out urinary tract infection (UTI) in children.

90 e 216Dx in comparison to UA for diagnosis of urinary tract infection (UTI) in children.

91 clinically relevant bacteria known to cause urinary tract infection (UTI) in millions of patients.

92 ing or withholding antibiotics for suspected urinary tract infection (UTI) in older patients.

93 nnecessary antibiotic treatment of suspected urinary tract infection (UTI) is common in long-term car

94 A significant proportion of urinary tract infection (UTI) patients experience recurr

95 Women with uncomplicated urinary tract infection (UTI) symptoms are commonly trea

96 National guidelines for pneumonia (PNA), urinary tract infection (UTI), and acute bacterial skin

97 r respiratory tract infection (RTI), skin or urinary tract infection (UTI), and antibiotic prescripti

98 ys, including surgical site infection (SSI), urinary tract infection (UTI), and lower respiratory tra

99 ysed urinary microbial ATP as a biomarker of urinary tract infection (UTI), confirming the capability

100 To investigate RNase 7's role in preventing urinary tract infection (UTI), we quantified urinary RNa

101 One such area is urinary tract infection (UTI), which is one of the most

102 gold standard diagnostic test for confirming urinary tract infection (UTI).

103 nd regulation of inflammation in response to urinary tract infection (UTI).

104 ta and future development of bacteriuria and urinary tract infection (UTI).

105 ory infection, intra-abdominal infection, or urinary tract infection (UTI).

106 Streptococcus agalactiae can cause urinary tract infection (UTI).

107 in vitro and disease severity in a model of urinary tract infection (UTI).

108 septic condition but has not been studied in urinary tract infection (UTI).

109 The most common infections were urinary tract infection (UTI; 46.8%) and pneumonia (28.2

110 Urinary tract infection (UTIs) was higher in CC group (4

111 li (ExPEC) is the leading cause in humans of urinary tract infection and bacteremia.

112 this question in a mouse model of recurrent urinary tract infection and found that a prior bladder i

113 diabetes, and graft function, posttransplant urinary tract infection and rejection treatment were imp

114 Urinary tract infection and rejection treatment were not

115 ger percent burn and with the development of urinary tract infection and sepsis postadmission, regard

116 ing methodology, among patients suspected of urinary tract infection at 11 sites in Indonesia.

117 fumarate for 8 months presented with fever, urinary tract infection caused by Escherichia coli, anal

118 ted intraabdominal infection, or complicated urinary tract infection caused by imipenem-nonsusceptibl

119 Our data reveal potential links for urinary tract infection development and several morbidit

120 rence to study medication, or development of urinary tract infection during the study.

121 reteric stenosis in 31 (44%) of 71 patients, urinary tract infection in 23 (32%), haematuria in 22 (3

122 events reported as related to treatment were urinary tract infection in one (1%) participant in the t

123 Antibiotic prescribing for a presumed urinary tract infection is often preceded by inappropria

124 t Escherichia coli and Enterococcus faecalis urinary tract infection isolates.

125 would not increase the risk of developing a urinary tract infection or increase the burden of use to

126 n quality indicators and catheter-associated urinary tract infection outcomes in intensive care units

127 nd no difference in complications, including urinary tract infection rates, between those using singl

128 staff, without detrimental impact on UC and urinary tract infection rates.

129 ora was 16.3% (95% CI 15.1-17.6) and that of urinary tract infection was 8.6% (7.7-9.5).

130 ent) and precipitating factors (for example, urinary tract infection) for delirium have been describe

131 alidomide-dexamethasone group (pneumonia and urinary tract infection).

132 ates of RTI, skin and soft-tissue infection, urinary tract infection, and bloodstream infection varie

133 h as kidney disorder, urinary stone disease, urinary tract infection, and cystic fibrosis.

134 etiologies for fever, prematurely diagnosing urinary tract infection, and prescribing unnecessary ant

135 italization with major infection (pneumonia, urinary tract infection, cellulitis and osteomyelitis, a

136 italization with major infection (pneumonia, urinary tract infection, cellulitis and osteomyelitis, a

137 erences in rates of postoperative pneumonia, urinary tract infection, Clostridium difficile colitis,

138 4 adverse events in the letrozole group were urinary tract infection, hypokalaemia, and left ventricu

139 Escherichia coli is the leading cause of urinary tract infection, one of the most common bacteria

140 IIB092 2100 mg: two severe adverse events of urinary tract infection, one severe adverse event of cha

141 sculoskeletal low back pain (nepholithiasis, urinary tract infection, osteomyelitis, cholecystitis, o

142 hospital discharge with a diagnosis code for urinary tract infection, pneumonia, cellulitis/osteomyel

143 c obstructive pulmonary disease, arrhythmia, urinary tract infection, septicemia, and stroke from 200

144 her an E. faecalis or Pseudomonas aeruginosa urinary tract infection, suggesting a role for urinary a

145 use only, particularly for outcomes such as urinary tract infection, urethral injury and quality of

146 The effect of complications, such as urinary tract infection, venous thromboembolism, and myo

147 Urinary tract infection-positive burn patients with alte

148 high rate of bacteriuria without documented urinary tract infection.

149 s of any age without signs and symptoms of a urinary tract infection.

150 e most common adverse events were nausea and urinary tract infection.

151 ia, in the absence of signs or symptoms of a urinary tract infection.

152 are test that can guide correct treatment of urinary tract infection.

153 regulating an inflammatory response during a urinary tract infection.

154 n mouse models of peritonitis, pneumonia and urinary tract infection.

155 modifiable factors like graft rejection and urinary tract infection.

156 comprised rejection, acute tubular necrosis, urinary tract infection/pyelonephritis, viral nephritis,

157 quired bloodstream infection, pneumonia, and urinary tract infection; all-cause ICU mortality; and le

158 ng Escherichia coli ( E. coli) isolated from urinary-tract infection (UTI) samples.

159 personnel and number of catheter-associated urinary tract infections (CAUTI) and central line-associ

160 e focused on the risk of catheter-associated urinary tract infections (CAUTI) caused by Escherichia c

161 ulting in false positive catheter-associated urinary tract infections (CAUTI).

162 Catheter-associated urinary tract infections (CAUTIs) are common hospital-ac

163 n detecting the onset of catheter-associated urinary tract infections (CAUTIs) is also demonstrated b

164 Complicated urinary tract infections (cUTIs) are responsible for a m

165 ally tested positive), and 71% in those with urinary tract infections (ie, resolution in 224 [71%] of

166 2 patients and in ten [28%] of 36 patients), urinary tract infections (in one [8%] of 12 and in six [

167 Recurrent urinary tract infections (R-UTIs) are the main cause of

168 Recurrent urinary tract infections (R-UTIs) are the main cause of

169 Recurrent urinary tract infections (rUTIs) are extremely common, w

170 sociates with an increased risk of recurrent urinary tract infections (rUTIs) linked to uropathogenic

171 Urinary tract infections (UTI) are one of the most commo

172 Diagnosing urinary tract infections (UTI) in nursing home residents

173 uropathogenic E. coli - the primary cause of urinary tract infections (UTIs) - can adhere to vaginal

174 Disorders such as recurrent urinary tract infections (UTIs) and interstitial cystiti

175 Urinary tract infections (UTIs) are a microbial disease

176 Urinary tract infections (UTIs) are common and in genera

177 Urinary tract infections (UTIs) are common in both inpat

178 Urinary tract infections (UTIs) are common, recurrent in

179 Urinary tract infections (UTIs) are the most commonly re

180 Urinary tract infections (UTIs) caused by Escherichia co

181 Urinary tract infections (UTIs) caused by uropathogenic

182 Urinary tract infections (UTIs) in children are among th

183 The treatment of urinary tract infections (UTIs) in kidney transplant rec

184 Urinary tract infections (UTIs) occur commonly, but rece

185 Urinary tract infections (UTIs) represent a major burden

186 Urinary tract infections (UTIs) typically evoke prompt a

187 Prior studies evaluating risk for severe urinary tract infections (UTIs) with sodium-glucose cotr

188 ble hematuria, migration, fragmentation, and urinary tract infections (UTIs) within 3 mo of transplan

189 domly assigned 609 patients with complicated urinary tract infections (UTIs), including acute pyelone

190 It is associated with urinary tract infections (UTIs), one of the most common

191 he acute pyelonephritis that can result from urinary tract infections (UTIs), which commonly ascend f

192 nd long durations of therapy for symptomatic urinary tract infections (UTIs), yet large-scale evaluat

193 s the major causative agent of uncomplicated urinary tract infections (UTIs).

194 cherichia coli (UPEC) a fitness advantage in urinary tract infections (UTIs).

195 caution), that less severe outcomes (such as urinary tract infections [UTIs] managed in the community

196 to identify potential mechanisms leading to urinary tract infections and associated morbidities in b

197 Escherichia coli associated with urinary tract infections and bacteremia has been intensi

198 range of diseases, including respiratory and urinary tract infections and bacteremia.

199 23 individuals diagnosed with polymicrobial urinary tract infections and found that most interaction

200 well described for ExPEC strains that cause urinary tract infections and meningitis, they have not b

201 nistration for the management of complicated urinary tract infections and pyelonephritis caused by su

202 ome may be used to predict susceptibility to urinary tract infections and sepsis in burn patients.

203 Severe urinary tract infections are commonly caused by sub-stra

204 Urinary tract infections caused by the bacterium Escheri

205 Frequent antibiotic treatment of urinary tract infections has resulted in the emergence o

206 h of nine antibiotics that are used to treat urinary tract infections in minutes.

207 The incidence rate for catheter-associated urinary tract infections is between 3% and 7% for each d

208 ndamycin (300 mg twice daily for 5 days) and urinary tract infections with cefixime (400 mg once dail

209 bserved 2 UC (ureteric leak and stenosis), 8 urinary tract infections, and 9 stent-related symptoms.

210 e diseases like sepsis, acute kidney injury, urinary tract infections, and HIV/AIDS.

211 a range of infections, including pneumonias, urinary tract infections, and septicemia, in otherwise h

212 treatment of complicated intra-abdominal and urinary tract infections, as well as hospital-acquired p

213 for most spending related to admissions for urinary tract infections, dehydration, heart failure, an

214 erichia coli, the primary causative agent of urinary tract infections, expresses type 1 and P pili re

215 ed 32 ventilator-associated pneumonia, eight urinary tract infections, five blood stream infections,

216 istration (FDA) for treatment of complicated urinary tract infections, including pyelonephritis, in a

217 a single site of infection (eg, complicated urinary tract infections, intra-abdominal infections), y

218 Escherichia coli (UPEC), a leading cause of urinary tract infections, is associated with prostate an

219 ory Activities, version 21.0), most commonly urinary tract infections, occurred more frequently with

220 l role in the innate immune response against urinary tract infections, the structural basis and mecha

221 richia coli (UPEC), the predominant cause of urinary tract infections, undergoes a transient intracel

222 nic matrix that are strictly associated with urinary tract infections.

223 ly prescribed drug in the treatment of acute urinary tract infections.

224 Escherichia coli (UPEC), the major cause of urinary tract infections.

225 ce, including Escherichia-Shigella linked to urinary tract infections.

226 al agents, for instance, in the treatment of urinary tract infections.

227 e 3 development in patients with complicated urinary tract infections.

228 l urine samples from patients diagnosed with urinary tract infections.

229 sed screening for abnormal vaginal flora and urinary tract infections.

230 step-down oral therapy to treat complicated urinary tract infections.

231 t that contains bacterial species related to urinary tract infections.

232 and inguinal hernias but less than that for urinary tract infections.

233 nd capsule-deficient mutants associated with urinary tract infections.

234 sign of diseases such as hemolytic anemia or urinary tract infections.

235 1.1%-100%) of prescriptions in uncomplicated urinary tract infections.

236 (54%) were reported from catheter-associated urinary tract infections.

237 n vitro biofilm formation and persistence in urinary tract infections.

238 tsS/BtsR importance during acute and chronic urinary-tract infections.

239 e origin of most bacterial infections in the urinary tract is often presumed to be the gut.

240 olvement of the urothelium in patterning the urinary tract is supported by evidence that CAKUTs can a

241 independent primary cell types of the human urinary tract (kidney and bladder) throughout the replic

242 Specifically, our study implicates urinary tract Lactobacillus and Enterobacteriaceae in pr

243 The lower urinary tract (LUT) and micturition reflexes are sexuall

244 Storage and voiding of urine from the lower urinary tract (LUT) must be timed precisely to occur in

245 Moreover, the presence of urinary tract malformation was associated with the need

246 can occur in patients with congenital lower urinary tract malformations (LUTM) even when managed dur

247 symptomatic bacteriuria commonly result from urinary tract malformations or bladder disturbances.

248 ons in CHRNA3 can cause bladder dysfunction, urinary tract malformations, and dysautonomia.

249 flow is a frequent cause of secondary upper urinary tract malformations.

250 that may increase the risk for USD, with the urinary tract microbiome holding more relevance for USD

251 AP) and performed a comprehensive screen for urinary tract microbiota signatures, metabolite, and cyt

252 tive in anxiety, neuropathic pain, and lower urinary tract models.

253 rimary stretch and pressure detectors in the urinary tract mostly remain unknown.

254 ree unrelated families with functional lower urinary tract obstruction and secondary CAKUT.

255 Emerging evidence indicates that congenital urinary tract obstruction triggers urothelial remodellin

256 ary ureteric bud (UB) branches can result in urinary tract obstruction.

257 diverse as sepsis, cardiorenal syndrome, and urinary tract obstruction.

258 epithelial cells in response to injury from urinary tract obstruction.

259 Congenital lower urinary-tract obstruction (LUTO) is caused by anatomical

260 shes a life-long persistent infection in the urinary tract of most people.

261 se model showed Isl1-expressing cells in the urinary tract of mouse embryos at E10.5 and distributed

262 rating endometriosis involving the bowel and urinary tract on abdominal ultrasonography and shows the

263 is, stroke, or myocardial infarction; minor: urinary tract or surgical site infection) and surgery du

264 Enterococcus spp (20%) occurred as urinary tract pathogens in kidney transplant recipients

265 dney epithelial cells and their infection by urinary tract pathogens.

266 greater need for surgical correction of the urinary tract pretransplant.

267 ABSTRACT: Lower urinary tract reflexes are mediated by peripheral affere

268 ], surgical site [SSI], and all other types [urinary tract, respiratory, other/unknown site]) and cal

269 ogenesis, basonuclin 2 was detected in lower urinary-tract rudiments.

270 ory-confirmed infections (respiratory tract, urinary tract, skin or soft tissue), antibiotic resistan

271 tion of contractility and function, in lower urinary tract SMCs.

272 ndins could be used to treat candidemia of a urinary tract source (CUTS) is unknown.

273 h hospital records to identify patients with urinary tract stones (N = 211,718) and cancer registrati

274 We analysed cancer risks in patients with urinary tract stones but some features of the generated

275 alculated after the last medical contact for urinary tract stones.

276 Although phages have been discovered in the urinary tract, such as phages that infect Escherichia co

277 Lower urinary tract symptoms (LUTS) are exceptionally common a

278 usly showed that patients with chronic lower urinary tract symptoms (LUTS) below the diagnostic cutof

279 eportedly an important factor inducing lower urinary tract symptoms (LUTS) including urinary frequenc

280 tients suffer from chronic, irritative lower urinary tract symptoms (LUTS).

281 le sclerosis (MS) develop a variety of lower urinary tract symptoms (LUTS).

282 Nearly all older men will experience lower urinary tract symptoms associated with benign prostatic

283 in seven UK hospitals with bothersome lower urinary tract symptoms or urinary retention secondary to

284 tigate TURP versus ThuVARP in men with lower urinary tract symptoms or urinary retention secondary to

285 -menopausal bleeding, rectal bleeding, lower urinary tract symptoms, haematuria, change in bowel habi

286 ion on Incontinence Questionnaire Male Lower Urinary Tract Symptoms, or ICIQ-MLUTS, and the Internati

287 use of other medications indicated for lower urinary tract symptoms.

288 g phages has therapeutic potential for lower urinary tract symptoms.

289 and progression of clinically relevant lower urinary tract symptoms.

290 plasia with good long-term results for lower urinary tract symptoms.

291 ysfunction, including incontinence and lower urinary tract symptoms; with the causes remaining unknow

292 als), congenital anomalies of the kidney and urinary tract (ten out of 55 individuals), and chronic g

293 e is known about unrecognized viruses of the urinary tract that potentially result in transmission.

294 CuCl2 was not excreted or accumulated in the urinary tract, thus allowing thorough pelvic exploration

295 mechanosensitive ion channel PIEZO2 in lower urinary tract tissues, where it is required for low-thre

296 omes included post-operative surgical (SSI), urinary tract (UTI), and C. difficile infections.

297 included postoperative surgical site (SSI), urinary tract (UTI), and Clostridioides difficile infect

298 Urothelial carcinomas of the upper urinary tract (UTUCs) are rare, with poorer stage-for-st

299 cteriaceae infect human gastrointestinal and urinary tracts, where they encounter different pH condit

300 ual risk of colonisation or infection of the urinary tract with fluoroquinolone-resistant Escherichia